Avacta Group plc (AVCT) Ordinary Shares 10p

Sell:63.00pBuy:65.00pPrice unchangedNo change

Market closed |
Prices delayed by at least 15 minutes
Sell:63.00p
Buy:65.00p
Change:Price unchangedNo change
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:63.00p
Buy:65.00p
Change:Price unchangedNo change
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open-
Previous close63.50p
Market cap£277.90m
P/E ratio-
Volume-
Dividend yield0.00%
EMS20000

Company information

Avacta Group plc is a United Kingdom-based life sciences company developing peptide drug conjugates (PDC) targeting anti-tumor payloads directly to the tumor. The Company is focused on the development of its proprietary ...

  • LocationUnited Kingdom
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyGBP
  • Shares in issue440.42m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Lightweight Charts™ provided by https://www.tradingview.com/.